Stockscreener 앱 받기
10.28
0.06%
0.0066
시간 외 거래:
10.28
0.0034
+0.03%
전일 마감가:
$10.27
열려 있는:
$10.28
하루 거래량:
6,055
Relative Volume:
0.34
시가총액:
$572.41M
수익:
-
순이익/손실:
-
주가수익비율:
-5.4374
EPS:
-1.89
순현금흐름:
-
1주 성능:
+0.36%
1개월 성능:
-0.13%
6개월 성능:
-80.23%
1년 성능:
-80.23%
1일 변동 폭
$10.27
$10.28
1주일 범위
$10.20
$10.30
52주 변동 폭
$10.07
$11.00
Churchill Capital Corp Xi Stock (CCXI) Company Profile
명칭
Churchill Capital Corp Xi
전화
(212) 380-7500
주소
640 FIFTH AVENUE 12TH FLOOR, NEW YORK, CA
Compare CCXI vs LION, XXI, UMAC, DMII, EVAC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CCXI
Churchill Capital Corp Xi
|
10.28 | 572.04M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
12.91 | 3.66B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.64 | 2.70B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
14.80 | 686.80M | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.05 | 640.19M | 0 | 4.19M | 0 | 0.065 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.15 | 594.41M | 0 | 8.92M | 0 | 0.1519 |
Churchill Capital Corp Xi Stock (CCXI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-11 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-10-11 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-10-08 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-10-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-07-07 | 업그레이드 | Stifel | Hold → Buy |
| 2021-05-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-05-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-05-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-05-07 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-05-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-03-02 | 재확인 | H.C. Wainwright | Buy |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2020-10-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-05-27 | 개시 | Wells Fargo | Overweight |
| 2020-05-12 | 재확인 | H.C. Wainwright | Buy |
| 2020-01-24 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-26 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-26 | 재확인 | Piper Jaffray | Overweight |
| 2019-03-27 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2019-02-11 | 개시 | Piper Jaffray | Overweight |
| 2018-09-07 | 개시 | B. Riley FBR | Neutral |
| 2018-08-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-06-28 | 개시 | Raymond James | Strong Buy |
| 2018-05-02 | 개시 | H.C. Wainwright | Buy |
| 2017-02-21 | 개시 | JMP Securities | Mkt Outperform |
| 2015-05-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2013-05-20 | 재확인 | Stifel | Buy |
| 2012-11-14 | 개시 | Stifel Nicolaus | Buy |
모두보기
Churchill Capital Corp Xi 주식(CCXI)의 최신 뉴스
Top SPAC and New Issue ETF (SPCK) Competitors 2026 - MarketBeat
Top Meshflow Acquisition (MESH) Competitors 2026 - MarketBeat
Top Inflection Point Acquisition Corp. VI (IPFX) Competitors 2026 - MarketBeat
Top Launchpad Cadenza Acquisition Corp I (LPCV) Competitors 2026 - MarketBeat
Top Mountain Lake Acquisition Corp. II (MLAA) Competitors 2026 - MarketBeat
Top Praetorian Acquisition (PTOR) Competitors 2026 - MarketBeat
Top Muzero Acquisition (MUZE) Competitors 2026 - MarketBeat
Top Aldabra 4 Liquidity Opportunity Vehicle (ALOV) Competitors 2026 - MarketBeat
Top Tailwind 2.0 Acquisition (TDWD) Competitors 2026 - MarketBeat
Top Infinite Eagle Acquisition (IEAG) Competitors 2026 - MarketBeat
Top KRAKacquisition (KRAQ) Competitors 2026 - MarketBeat
Top Iron Horse Acquisitions II (IRHO) Competitors 2026 - MarketBeat
Top Viking Acquisition Corp. I (VACI) Competitors 2026 - MarketBeat
Churchill Capital Corp XI Units (CCXIU) Institutional Ownership 2026 - MarketBeat
Space Asset Acquisition (SAAQ) Stock Trends and Sentiment 2026 - MarketBeat
Top Soren Acquisition (SORN) Competitors 2026 - MarketBeat
Top X3 Acquisition (XCBE) Competitors 2026 - MarketBeat
Top Vine Hill Capital Investment Corp. II (VHCP) Competitors 2026 - MarketBeat
Top AI Infrastructure Acquisition (AIIA) Competitors 2026 - MarketBeat
Churchill Capital Corp IX Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Immuneering Corporation Reports Q1 2026 Financial Results and Announces Positive Phase 2a Pancreatic Cancer Trial Data - Minichart
Apollo Global Management, Inc. 8-K Filing May 2026: Common Stock, Preferred Shares, and Subordinated Notes Registered on NYSE - Minichart
A.C.L. Construction Ltd.: Shareholders Board Members Managers and Company Profile | CA00092W1086 - marketscreener.com
Top EQV Ventures Acquisition Corp. II (EVAC) Competitors 2026 - MarketBeat
Corvus Pharmaceuticals Reports Positive Final Phase 1 Results for Soquelitinib in Atopic Dermatitis at SID 2026 Annual Meeting 16 - Minichart
Churchill Capital Corp XI Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Trust income drives Churchill Capital XI (CCXI) Q1 2026 profit - Stock Titan
Top Range Capital Acquisition Corp II (RNGT) Competitors 2026 - MarketBeat
MMCAP entities report 2.7M Churchill Capital Corp XI shares (CCXI) - Stock Titan
Viking Acquisition Corp. I (VACI) Stock Trends and Sentiment 2026 - MarketBeat
Number of shareholders of Churchill Capital Corp XI – NASDAQ:CCXIU - TradingView
Is Churchill XI (CCXI) a once in a decade opportunity? (Motionless) 2026-05-08Seasonal Patterns - newser.com
CCXIU | Churchill Capital Corp XI Insider Trading - Quiver Quantitative
Vector Science and Therapeutics Corp.: Performance & Quotes, PAIN Stock Price on Toronto S.E. Exchange - marketscreener.com
Top Lionheart Holdings Class A Ordinary Shares (CUB) Competitors 2026 - MarketBeat
Top Alussa Energy Acquisition Corp. II (ALUB) Competitors 2026 - MarketBeat
Alussa Energy Acquisition Corp. II (ALUB) Stock Trends and Sentiment 2026 - MarketBeat
Top Xsolla SPAC 1 (XSLL) Competitors 2026 - MarketBeat
Top Silicon Valley Acquisition (SVAQ) Competitors 2026 - MarketBeat
Lafayette Digital Acquisition Corp. I (ZKP) Stock Trends and Sentiment 2026 $ZKP - MarketBeat
Churchill Capital Corp Xi (CCXI) 재무 분석
Churchill Capital Corp Xi (CCXI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.49%
0.20%
자본화:
|
볼륨(24시간):